Ion channels and migraine

Headache

Volumn 54, Issue 4, 2014, Pages 619-639

  Yan, Jin ^a   Dussor, Gregory ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

acid sensing ion channel; dural afferent; transient receptor potential cation channel A1; transient receptor potential cation channel V1; transient receptor potential cation channel V4; TWIK related spinal cord potassium channel

Indexed keywords

ACID SENSING ION CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; ION CHANNEL; PURINERGIC P2X RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4;

CHANNELOPATHY; HUMAN; MAST CELL; MAST CELL DEGRANULATION; MIGRAINE; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; REVIEW; SENSITIZATION; SENSORY NERVE; SUPERIOR SAGITTAL SINUS; TRIGEMINAL NERVE; TRIGEMINUS GANGLION; ANIMAL; CENTRAL NERVOUS SYSTEM SENSITIZATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CENTRAL NERVOUS SYSTEM SENSITIZATION; HUMANS; ION CHANNELS; MIGRAINE DISORDERS;

EID: 84897568931     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12323     Document Type: Review

References (197)

1. Goadsby PJ, Lipton RB, Ferrari MD,. Migraine-Current understanding and treatment. N Engl J Med. 2002; 346: 257-270.
2. Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olesen J,. Classification of primary headaches. Neurology. 2004; 63: 427-435.
3. Stewart WF, Wood C, Reed ML, Roy J, Lipton RB,. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008; 28: 1170-1178.
4. Lipton RB, Stewart WF, von Korff M,. Burden of migraine: Societal costs and therapeutic opportunities. Neurology. 1997; 48: S4-S9.
5. Levy D,. Migraine pain and nociceptor activation-Where do we stand? Headache. 2010; 50: 909-916.
6. Pietrobon D, Striessnig J,. Neurobiology of migraine. Nat Rev Neurosci. 2003; 4: 386-398.
7. Kelman L,. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007; 27: 394-402.
8. Martin PR,. Behavioral management of migraine headache triggers: Learning to cope with triggers. Curr Pain Headache Rep. 2010; 14: 221-227.
9. Aukerman G, Knutson D, Miser WF,. Management of the acute migraine headache. Am Fam Physician. 2002; 66: 2123-2130.
10. Legg N, Khalil N,. Visual dysfunction in migraine with aura. Cephalalgia. 1995; 15: 536-537.
11. Chronicle EP, Wilkins AJ, Coleston DM,. Thresholds for detection of a target against a background grating suggest visual dysfunction in migraine with aura but not migraine without aura. Cephalalgia. 1995; 15: 117-122.
12. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW,. Visual cortex excitability in migraine with and without aura. Headache. 2001; 41: 565-572.
13. Cohen GL,. Migraine prophylactic drugs work via ion channels. Med Hypotheses. 2005; 65: 114-122.
14. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR,. Neurobiology of migraine. Neuroscience. 2009; 161: 327-341.
15. Messlinger K,. Migraine: Where and how does the pain originate? Exp Brain Res. 2009; 196: 179-193.
16. Hoskin KL, Zagami AS, Goadsby PJ,. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat. J Anat. 1999; 194 (Pt 4): 579-588.
17. Strassman AM, Mineta Y, Vos BP,. Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J Neurosci. 1994; 14: 3725-3735.
18. Mayberg MR, Zervas NT, Moskowitz MA,. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol. 1984; 223: 46-56.
19. Strassman AM, Levy D,. Response properties of dural nociceptors in relation to headache. J Neurophysiol. 2006; 95: 1298-1306.
20. Strassman AM, Raymond SA, Burstein R,. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996; 384: 560-564.
21. Bove GM, Moskowitz MA,. Primary afferent neurons innervating guinea pig dura. J Neurophysiol. 1997; 77: 299-308.
22. Ray BS, Wolff HG,. Experimental studies on headache: Pain sensitive structures of the head and their significance in headache. Arch Surg. 1940; 41: 813-856.
23. Perini F, D'Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005; 45: 926-931.
24. Sarchielli P, Alberti A, Floridi A, Gallai V,. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology. 2001; 57: 132-134.
25. Dimlich RV, Keller JT, Strauss TA, Fritts MJ,. Linear arrays of homogeneous mast cells in the dura mater of the rat. J Neurocytol. 1991; 20: 485-503.
26. Strassman AM, Weissner W, Williams M, Ali S, Levy D,. Axon diameters and intradural trajectories of the dural innervation in the rat. J Comp Neurol. 2004; 473: 364-376.
27. Rozniecki JJ, Dimitriadou V, Lambracht-Hall M, Pang X, Theoharides TC,. Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res. 1999; 849: 1-15.
28. Theoharides TC, Spanos C, Pang X, et al. Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology. 1995; 136: 5745-5750.
29. Ottosson A, Edvinsson L,. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia. 1997; 17: 166-174.
30. Reuter U, Bolay H, Jansen-Olesen I, et al. Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain. 2001; 124: 2490-2502.
31. Levy D,. Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep. 2009; 13: 237-240.
32. Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM,. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain. 2007; 130: 166-176.
33. Zhang XC, Strassman AM, Burstein R, Levy D,. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther. 2007; 322: 806-812.
34. Yan J, Wei X, Bischoff C, Edelmayer RM, Dussor G,. pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators. Headache. 2013; 53: 1250-1261.
35. Smith JH, Butterfield JH, Pardanani A, Deluca GC, Cutrer FM,. Neurologic symptoms and diagnosis in adults with mast cell disease. Clin Neurol Neurosurg. 2011; 113: 570-574.
36. Boes T, Levy D,. Influence of sex, estrous cycle, and estrogen on intracranial dural mast cells. Cephalalgia. 2012; 32: 924-931.
37. Mayevsky A, Zeuthen T, Chance B,. Measurements of extracellular potassium, ECoG and pyridine nucleotide levels during cortical spreading depression in rats. Brain Res. 1974; 76: 347-349.
38. Csiba L, Paschen W, Mies G,. Regional changes in tissue pH and glucose content during cortical spreading depression in rat brain. Brain Res. 1985; 336: 167-170.
39. Van Harreveld A,. Compounds in brain extracts causing spreading depression of cerebral cortical activity and contraction of crustacean muscle. J Neurochem. 1959; 3: 300-315.
40. Jander S, Schroeter M, Peters O, Witte OW, Stoll G,. Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab. 2001; 21: 218-225.
41. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA,. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002; 8: 136-142.
42. Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R,. Activation of meningeal nociceptors by cortical spreading depression: Implications for migraine with aura. J Neurosci. 2010; 30: 8807-8814.
43. Karatas H, Erdener SE, Gursoy-Ozdemir Y, et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013; 339: 1092-1095.
44. Harriott AM, Gold MS,. Electrophysiological properties of dural afferents in the absence and presence of inflammatory mediators. J Neurophysiol. 2009; 101: 3126-3134.
45. Schepelmann K, Ebersberger A, Pawlak M, Oppmann M, Messlinger K,. Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat. Neuroscience. 1999; 90: 543-554.
46. Huang D, Li S, Dhaka A, Story GM, Cao YQ,. Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura. Mol Pain. 2012; 8: 66.
47. Yan J, Edelmayer RM, Wei X, De Felice M, Porreca F, Dussor G,. Dural afferents express acid-sensing ion channels: A role for decreased meningeal pH in migraine headache. Pain. 2011; 152: 106-113.
48. Wemmie JA, Price MP, Welsh MJ,. Acid-sensing ion channels: Advances, questions and therapeutic opportunities. Trends Neurosci. 2006; 29: 578-586.
49. Lingueglia E,. Acid-sensing ion channels in sensory perception. J Biol Chem. 2007; 282: 17325-17329.
50. Baron A, Voilley N, Lazdunski M, Lingueglia E,. Acid sensing ion channels in dorsal spinal cord neurons. J Neurosci. 2008; 28: 1498-1508.
51. Price MP, Snyder PM, Welsh MJ,. Cloning and expression of a novel human brain Na+ channel. J Biol Chem. 1996; 271: 7879-7882.
52. Waldmann R, Champigny G, Voilley N, Lauritzen I, Lazdunski M,. The mammalian degenerin MDEG, an amiloride-sensitive cation channel activated by mutations causing neurodegeneration in Caenorhabditis elegans. J Biol Chem. 1996; 271: 10433-10436.
53. Wu L-J, Duan B, Mei Y-D, et al. Characterization of acid-sensing ion channels in dorsal horn neurons of rat spinal cord. J Biol Chem. 2004; 279: 43716-43724.
54. Mamet J, Baron A, Lazdunski M, Voilley N,. Proinflammatory mediators, stimulators of sensory neuron excitability via the expression of acid-sensing ion channels. J Neurosci. 2002; 22: 10662-10670.
55. Voilley N, de Weille J, Mamet J, Lazdunski M,. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci. 2001; 21: 8026-8033.
56. Yagi J, Wenk HN, Naves LA, McCleskey EW,. Sustained currents through ASIC3 ion channels at the modest pH changes that occur during myocardial ischemia. Circ Res. 2006; 99: 501-509.
57. Waldmann R, Bassilana F, de Weille J, Champigny G, Heurteaux C, Lazdunski M,. Molecular cloning of a non-inactivating proton-gated Na+ channel specific for sensory neurons. J Biol Chem. 1997; 272: 20975-20978.
58. Jones RC III, Xu L, Gebhart GF,. The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci. 2005; 25: 10981-10989.
59. Molliver DC, Immke DC, Fierro L, Pare M, Rice FL, McCleskey EW,. ASIC3, an acid-sensing ion channel, is expressed in metaboreceptive sensory neurons. Mol Pain. 2005; 1: 35.
60. Page AJ, Brierley SM, Martin CM, et al. Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. Gut. 2005; 54: 1408-1415.
61. Sutherland SP, Benson CJ, Adelman JP, McCleskey EW,. Acid-sensing ion channel 3 matches the acid-gated current in cardiac ischemia-sensing neurons. Proc Natl Acad Sci U S A. 2001; 98: 711-716.
62. Deval E, Noel J, Gasull X, et al. Acid-sensing ion channels in postoperative pain. J Neurosci. 2011; 31: 6059-6066.
63. Sluka KA, Radhakrishnan R, Benson CJ, et al. ASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammation. Pain. 2007; 129: 102-112.
64. Burstein R,. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2001; 89: 107-110.
65. Durham PL, Masterson CG,. Two mechanisms involved in trigeminal CGRP release: Implications for migraine treatment. Headache. 2013; 53: 67-80.
66. Holland PR, Akerman S, Andreou AP, Karsan N, Wemmie JA, Goadsby PJ,. Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura. Ann Neurol. 2012; 72: 559-563.
67. De Young MB, Nemeth EF, Scarpa A,. Measurement of the internal pH of mast cell granules using microvolumetric fluorescence and isotopic techniques. Arch Biochem Biophys. 1987; 254: 222-233.
68. Lambert GA, Michalicek J,. Cortical spreading depression reduces dural blood flow-A possible mechanism for migraine pain? Cephalalgia. 1994; 14: 430-436, discussion 393-434.
69. Ramsey IS, Delling M, Clapham DE,. An introduction to TRP channels. Annu Rev Physiol. 2006; 68: 619-647.
70. Liu M, Liu MC, Magoulas C, Priestley JV, Willmott NJ,. Versatile regulation of cytosolic Ca2+ by vanilloid receptor I in rat dorsal root ganglion neurons. J Biol Chem. 2003; 278: 5462-5472.
71. Karai LJ, Russell JT, Iadarola MJ, Olah Z,. Vanilloid receptor 1 regulates multiple calcium compartments and contributes to Ca2+-induced Ca2+ release in sensory neurons. J Biol Chem. 2004; 279: 16377-16387.
72. Vriens J, Appendino G, Nilius B,. Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol. 2009; 75: 1262-1279.
73. Numazaki M, Tominaga M,. Nociception and TRP channels. Curr Drug Targets CNS Neurol Disord. 2004; 3: 479-485.
74. Jordt SE, Bautista DM, Chuang HH, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature. 2004; 427: 260-265.
75. Fajardo O, Meseguer V, Belmonte C, Viana F,. TRPA1 channels mediate cold temperature sensing in mammalian vagal sensory neurons: Pharmacological and genetic evidence. J Neurosci. 2008; 28: 7863-7875.
76. Nassini R, Materazzi S, De Siena G, De Cesaris F, Geppetti P,. Transient receptor potential channels as novel drug targets in respiratory diseases. Curr Opin Investig Drugs. 2010; 11: 535-542.
77. McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A. 2007; 104: 13525-13530.
78. Bautista DM, Jordt SE, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell. 2006; 124: 1269-1282.
79. Bessac BF, Jordt SE,. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda). 2008; 23: 360-370.
80. Andre E, Campi B, Materazzi S, et al. Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest. 2008; 118: 2574-2582.
81. Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 2004; 41: 849-857.
82. Bautista DM, Movahed P, Hinman A, et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci U S A. 2005; 102: 12248-12252.
83. Taylor-Clark TE, Ghatta S, Bettner W, Undem BJ,. Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol Pharmacol. 2009; 75: 820-829.
84. Trevisani M, Siemens J, Materazzi S, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A. 2007; 104: 13519-13524.
85. Materazzi S, Nassini R, Andre E, et al. Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A. 2008; 105: 12045-12050.
86. Basbaum AI, Bautista DM, Scherrer G, Julius D,. Cellular and molecular mechanisms of pain. Cell. 2009; 139: 267-284.
87. Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron. 2010; 66: 671-680.
88. Corey DP, Garcia-Anoveros J, Holt JR, et al. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature. 2004; 432: 723-730.
89. Kwan KY, Glazer JM, Corey DP, Rice FL, Stucky CL,. TRPA1 modulates mechanotransduction in cutaneous sensory neurons. J Neurosci. 2009; 29: 4808-4819.
90. Kerstein PC, del Camino D, Moran MM, Stucky CL,. Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors. Mol Pain. 2009; 5: 19.
91. Edelmayer RM, Le LN, Yan J, et al. Activation of TRPA1 on dural afferents: A potential mechanism of headache pain. Pain. 2012; 153: 1949-1958.
92. Nassini R, Materazzi S, Vriens J, et al. The "headache tree" via umbellulone and TRPA1 activates the trigeminovascular system. Brain. 2012; 135: 376-390.
93. Materazzi S, Benemei S, Fusi C, et al. Parthenolide inhibits nociception and neurogenic vasodilatation in the trigeminovascular system by targeting the TRPA1 channel. Pain. 2013; 154: 2750-2758.
94. Wantke F, Focke M, Hemmer W, et al. Exposure to formaldehyde and phenol during an anatomy dissecting course: Sensitizing potency of formaldehyde in medical students. Allergy. 2000; 55: 84-87.
95. Irlbacher K, Meyer BU,. Nasally triggered headache. Neurology. 2002; 58: 294.
96. Guo A, Vulchanova L, Wang J, Li X, Elde R,. Immunocytochemical localization of the vanilloid receptor 1 (VR1): Relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci. 1999; 11: 946-958.
97. Ichikawa H, Sugimoto T,. VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion. Brain Res. 2001; 890: 184-188.
98. Caterina MJ, Julius D,. The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci. 2001; 24: 487-517.
99. Jordt SE, Tominaga M, Julius D,. Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci U S A. 2000; 97: 8134-8139.
100. Carreno O, Corominas R, Fernandez-Morales J, et al. SNP variants within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B: 94-103.
101. Shimizu T, Toriumi H, Sato H, et al. Distribution and origin of TRPV1 receptor-containing nerve fibers in the dura mater of rat. Brain Res. 2007; 1173: 84-91.
102. Doods H, Arndt K, Rudolf K, Just S,. CGRP antagonists: Unravelling the role of CGRP in migraine. Trends Pharmacol Sci. 2007; 28: 580-587.
103. Akerman S, Kaube H, Goadsby PJ,. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol. 2003; 140: 718-724.
104. Nicoletti P, Trevisani M, Manconi M, et al. Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia. 2008; 28: 9-17.
105. Szallasi A, Cortright DN, Blum CA, Eid SR,. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov. 2007; 6: 357-372.
106. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999; 400: 452-457.
107. Huang SM, Bisogno T, Trevisani M, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A. 2002; 99: 8400-8405.
108. Hwang SW, Cho H, Kwak J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci U S A. 2000; 97: 6155-6160.
109. Ahern GP, Wang X, Miyares RL,. Polyamines are potent ligands for the capsaicin receptor TRPV1. J Biol Chem. 2006; 281: 8991-8995.
110. Cuypers E, Yanagihara A, Karlsson E, Tytgat J,. Jellyfish and other cnidarian envenomations cause pain by affecting TRPV1 channels. FEBS Lett. 2006; 580: 5728-5732.
111. Siemens J, Zhou S, Piskorowski R, et al. Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature. 2006; 444: 208-212.
112. Trevisani M, Smart D, Gunthorpe MJ, et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci. 2002; 5: 546-551.
113. Chuang HH, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature. 2001; 411: 957-962.
114. Moriyama T, Higashi T, Togashi K, et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain. 2005; 1: 3.
115. Tominaga M, Wada M, Masu M,. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci U S A. 2001; 98: 6951-6956.
116. Negri L, Lattanzi R, Giannini E, et al. Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: Focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. J Neurosci. 2006; 26: 6716-6727.
117. Diamond S, Freitag F, Phillips SB, Bernstein JE, Saper JR,. Intranasal civamide for the acute treatment of migraine headache. Cephalalgia. 2000; 20: 597-602.
118. Anand P, Bley K,. Topical capsaicin for pain management: Therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth. 2011; 107: 490-502.
119. Fusco BM, Barzoi G, Agro F,. Repeated intranasal capsaicin applications to treat chronic migraine. Br J Anaesth. 2003; 90: 812.
120. Gavva NR, Treanor JJ, Garami A, et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain. 2008; 136: 202-210.
121. Summ O, Holland PR, Akerman S, Goadsby PJ,. TRPV1 receptor blockade is ineffective in different in vivo models of migraine. Cephalalgia. 2011; 31: 172-180.
122. Lambert GA, Davis JB, Appleby JM, Chizh BA, Hoskin KL, Zagami AS,. The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. Naunyn Schmiedebergs Arch Pharmacol. 2009; 380: 311-325.
123. Chizh BA, O'Donnell MB, Napolitano A, et al. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain. 2007; 132: 132-141.
124. Kaube H, Hoskin KL, Goadsby PJ,. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia. 1992; 12: 133-136.
125. Levy D, Strassman AM,. Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura. J Neurophysiol. 2002; 88: 3021-3031.
126. Liedtke W, Tobin DM, Bargmann CI, Friedman JM,. Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2003; 100 (Suppl. 2): 14531-14536.
127. Vriens J, Watanabe H, Janssens A, Droogmans G, Voets T, Nilius B,. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc Natl Acad Sci U S A. 2004; 101: 396-401.
128. Watanabe H, Davis JB, Smart D, et al. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J Biol Chem. 2002; 277: 13569-13577.
129. Liedtke W, Choe Y, Marti-Renom MA, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell. 2000; 103: 525-535.
130. Mizuno A, Matsumoto N, Imai M, Suzuki M,. Impaired osmotic sensation in mice lacking TRPV4. Am J Physiol Cell Physiol. 2003; 285: C96-C101.
131. Suzuki M, Mizuno A, Kodaira K, Imai M,. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem. 2003; 278: 22664-22668.
132. Kitahara T, Li HS, Balaban CD,. Changes in transient receptor potential cation channel superfamily V (TRPV) mRNA expression in the mouse inner ear ganglia after kanamycin challenge. Hear Res. 2005; 201: 132-144.
133. Wei X, Edelmayer RM, Yan J, Dussor G,. Activation of TRPV4 on dural afferents produces headache-related behavior in a preclinical rat model. Cephalalgia. 2011; 31: 1595-1600.
134. Burstein R, Cutrer MF, Yarnitsky D,. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000; 123 (Pt 8): 1703-1709.
135. Grant AD, Cottrell GS, Amadesi S, et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol. 2007; 578: 715-733.
136. Cenac N, Altier C, Chapman K, Liedtke W, Zamponi G, Vergnolle N,. Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology. 2008; 135: 937-946. 946 e931-932.
137. Sipe WE, Brierley SM, Martin CM, et al. Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G1288-G1298.
138. Alessandri-Haber N, Joseph E, Dina OA, Liedtke W, Levine JD,. TRPV4 mediates pain-related behavior induced by mild hypertonic stimuli in the presence of inflammatory mediator. Pain. 2005; 118: 70-79.
139. Bautista DM, Siemens J, Glazer JM, et al. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature. 2007; 448: 204-208.
140. Colburn RW, Lubin ML, Stone DJ Jr, et al. Attenuated cold sensitivity in TRPM8 null mice. Neuron. 2007; 54: 379-386.
141. Dhaka A, Murray AN, Mathur J, Earley TJ, Petrus MJ, Patapoutian A,. TRPM8 is required for cold sensation in mice. Neuron. 2007; 54: 371-378.
142. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH,. An association between migraine and cutaneous allodynia. Ann Neurol. 2000; 47: 614-624.
143. Chasman DI, Schurks M, Anttila V, et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet. 2011; 43: 695-698.
144. Freilinger T, Anttila V, de Vries B, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet. 2012; 44: 777-782.
145. Ghosh J, Pradhan S, Mittal B,. Genome-wide-associated variants in migraine susceptibility: A replication study from north India. Headache. 2013; 53: 1583-1594.
146. Newsom J, Holt JL, Neubert JK, Caudle R, Ahn AH,. A high density of TRPM8 expressing sensory neurons in specialized structures of the head. Abstract retrieved from Society for Neuroscience. 2012.
147. Burnstock G,. P2X receptors in sensory neurones. Br J Anaesth. 2000; 84: 476-488.
148. Ford AP,. In pursuit of P2X3 antagonists: Novel therapeutics for chronic pain and afferent sensitization. Purinergic Signal. 2012; 8: 3-26.
149. Burnstock G,. Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther. 2006; 110: 433-454.
150. Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN,. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 1995; 377: 428-431.
151. North RA,. Molecular physiology of P2X receptors. Physiol Rev. 2002; 82: 1013-1067.
152. Staikopoulos V, Sessle BJ, Furness JB, Jennings EA,. Localization of P2X2 and P2X3 receptors in rat trigeminal ganglion neurons. Neuroscience. 2007; 144: 208-216.
153. Bradbury EJ, Burnstock G, McMahon SB,. The expression of P2X3 purinoreceptors in sensory neurons: Effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci. 1998; 12: 256-268.
154. Ruan HZ, Moules E, Burnstock G,. Changes in P2X3 purinoceptors in sensory ganglia of the mouse during embryonic and postnatal development. Histochem Cell Biol. 2004; 122: 539-551.
155. Ambalavanar R, Moritani M, Dessem D,. Trigeminal P2X3 receptor expression differs from dorsal root ganglion and is modulated by deep tissue inflammation. Pain. 2005; 117: 280-291.
156. Simonetti M, Fabbro A, D'Arco M, et al. Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin. Mol Pain. 2006; 2: 11.
157. D'Arco M, Giniatullin R, Simonetti M, et al. Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons. J Neurosci. 2007; 27: 8190-8201.
158. Fabbretti E, D'Arco M, Fabbro A, Simonetti M, Nistri A, Giniatullin R,. Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci. 2006; 26: 6163-6171.
159. Simonetti M, Giniatullin R, Fabbretti E,. Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons. J Biol Chem. 2008; 283: 18743-18752.
160. King BF, Ziganshina LE, Pintor J, Burnstock G,. Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH. Br J Pharmacol. 1996; 117: 1371-1373.
161. Wildman SS, King BF, Burnstock G,. Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH. Br J Pharmacol. 1998; 123: 1214-1220.
162. Gnanasekaran A, Sundukova M, van den Maagdenberg AM, Fabbretti E, Nistri A,. Lipid rafts control P2X3 receptor distribution and function in trigeminal sensory neurons of a transgenic migraine mouse model. Mol Pain. 2011; 7: 77.
163. Schock SC, Munyao N, Yakubchyk Y, et al. Cortical spreading depression releases ATP into the extracellular space and purinergic receptor activation contributes to the induction of ischemic tolerance. Brain Res. 2007; 1168: 129-138.
164. Masterson CG, Durham PL,. DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons. Headache. 2010; 50: 1424-1439.
165. Gribkoff VK, Starrett JE Jr, Dworetzky SI,. Maxi-K potassium channels: Form, function, and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist. 2001; 7: 166-177.
166. Robitaille R, Charlton MP,. Presynaptic calcium signals and transmitter release are modulated by calcium-activated potassium channels. J Neurosci. 1992; 12: 297-305.
167. Akerman S, Holland PR, Lasalandra MP, Goadsby PJ,. Inhibition of trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK/BK[Ca]) channel opening. Pain. 2010; 151: 128-136.
168. Lu R, Lukowski R, Sausbier M, et al. BK channels expressed in sensory neurons modulate inflammatory pain in mice. Pain. 2014; 155: 556-565.
169. Levy D, Strassman AM,. Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol. 2002; 538: 483-493.
170. Vaughn AH, Gold MS,. Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents. J Neurosci. 2010; 30: 7878-7888.
171. Gold MS, Traub RJ,. Cutaneous and colonic rat DRG neurons differ with respect to both baseline and PGE2-induced changes in passive and active electrophysiological properties. J Neurophysiol. 2004; 91: 2524-2531.
172. Fidan I, Yuksel S, Ymir T, Irkec C, Aksakal FN,. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol. 2006; 171: 184-188.
173. Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006; 46: 200-207.
174. Huang M, Pang X, Karalis K, Theoharides TC,. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in apolipoprotein E knockout mice. Cardiovasc Res. 2003; 59: 241-249.
175. Melemedjian OK, Asiedu MN, Tillu DV, et al. IL-6- and NGF-induced rapid control of protein synthesis and nociceptive plasticity via convergent signaling to the eIF4F complex. J Neurosci. 2010; 30: 15113-15123.
176. Yan J, Melemedjian OK, Price TJ, Dussor G,. Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain. 2012; 8: 6.
177. Stewart WF, Lipton RB, Celentano DD, Reed ML,. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992; 267: 64-69.
178. Lipton RB, Stewart WF,. Migraine in the United States: A review of epidemiology and health care use. Neurology. 1993; 43: S6-S10.
179. Scheff NN, Gold MS,. Sex differences in the inflammatory mediator-induced sensitization of dural afferents. J Neurophysiol. 2011; 106: 1662-1668.
180. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996; 87: 543-552.
181. Pietrobon D,. Calcium channels and migraine. Biochim Biophys Acta. 2013; 1828: 1655-1665.
182. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003; 33: 192-196.
183. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005; 366: 371-377.
184. Pietrobon D,. Familial hemiplegic migraine. Neurother. 2007; 4: 274-284.
185. de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM,. Molecular genetics of migraine. Hum Genet. 2009; 126: 115-132.
186. Lafreniere RG, Cader MZ, Poulin JF, et al. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med. 2010; 16: 1157-1160.
187. Hodgkin AL, Huxley AF,. Potassium leakage from an active nerve fibre. J Physiol. 1947; 106: 341-367.
188. Enyedi P, Czirjak G,. Molecular background of leak K+ currents: Two-pore domain potassium channels. Physiol Rev. 2010; 90: 559-605.
189. Duprat F, Lesage F, Fink M, Reyes R, Heurteaux C, Lazdunski M,. TASK, a human background K+ channel to sense external pH variations near physiological pH. EMBO J. 1997; 16: 5464-5471.
190. Lafreniere RG, Rouleau GA,. Migraine: Role of the TRESK two-pore potassium channel. Int J Biochem Cell Biol. 2011; 43: 1533-1536.
191. Liu P, Xiao Z, Ren F, et al. Functional analysis of a migraine-associated TRESK K+ channel mutation. J Neurosci. 2013; 33: 12810-12824.
192. Dobler T, Springauf A, Tovornik S, et al. TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones. J Physiol. 2007; 585: 867-879.
193. Liu C, Au JD, Zou HL, Cotten JF, Yost CS,. Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics. Anesth Analg. 2004; 99: 1715-1722. table of contents.
194. Andres-Enguix I, Shang L, Stansfeld PJ, et al. Functional analysis of missense variants in the TRESK (KCNK18) K channel. Sci Rep. 2012; 2: 237.
195. Gu W, Schlichthorl G, Hirsch JR, et al. Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2. J Physiol. 2002; 539: 657-668.
196. Xian Tao L, Dyachenko V, Zuzarte M, et al. The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle. Cardiovasc Res. 2006; 69: 86-97.
197. Maher BH, Griffiths LR,. Identification of molecular genetic factors that influence migraine. Mol Genet Genomics. 2011; 285: 433-446.